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ABSTRACT
Group II introns are self-splicing mobile genetic
retroelements. The spliced intron RNA and the
intron-encoded protein (IEP) form ribonucleopro-
tein particles (RNPs) that recognize and invade
specific DNA target sites. The IEP is a reverse
transcriptase/maturase that may bear a C-terminal
endonuclease domain enabling the RNP to cleave
the target DNA strand to prime reverse transcrip-
tion. However, some mobile introns, such as RmInt1,
lack the En domain but nevertheless retrohome effi-
ciently to transient single-stranded DNA target sites
at a DNA replication fork. Their mobility is associated
with host DNA replication, and they use the nascent
lagging strand as a primer for reverse transcription.
We searched for proteins that interact with RmInt1
RNPs and direct these RNPs to the DNA replication
fork. Co-immunoprecipitation assays suggested that
DnaN (the -sliding clamp), a component of DNA
polymerase III, interacts with the protein component
of the RmInt1 RNP. Pulldown assays, far-western
blots and biolayer interferometry supported this in-
teraction. Peptide binding assays also identified a
putative DnaN-interacting motif in the RmInt1 IEP
structurally conserved in group II intron IEPs. Our
results suggest that intron RNP interacts with the
-sliding clamp of the DNA replication machinery,
favouring reverse splicing into the transient ssDNA
at DNA replication forks.
INTRODUCTION
Group II introns are self-splicing RNAs and mobile ge-
netic retroelements identified in the genome of organelles
(mitochondria and chloroplasts of lower eukaryotes and
plants), bacteria and archaea (1–4). Group II introns are
absent from the nuclear genomes of eukaryotes (5–8), but
are thought to be the predecessor of the spliceosome (9) and
to have played an important role in the evolution of several
features of eukaryotic cell organization.
Group II introns consist of a catalytically active intron
RNA (ribozyme) with a conserved secondary structure con-
sisting of six interacting domains (DI–DVI) (10–12), and
a multifunctional intron-encoded protein (IEP) encoded
within DIV. Most IEPs have an N-terminal reverse tran-
scriptase domain (RT) and an RNA-binding domain (X)
that has been associated with RNA splicing or maturase ac-
tivity. Some IEPs have DNA-binding (D) and endonuclease
(En) domains after the X domain. The RT domain contains
several blocks of conserved amino acids present in retrovi-
ral RTs (RT 1-7) with an additional conserved block (RT
0) and insertions between other conserved sequence blocks
(RT 2a, 3a, 4a and 7a) (13,14).
Group II intron mobility is mediated by ribonucleopro-
tein particles (RNPs) consisting of the IEP and the spliced
intron RNA (15,16). Several studies of RNPs assembled
in vitro and in vivo have suggested that these particles are
formed by an IEP dimer bound to a single lariat RNA
(13,15,17–19), but a recent study of the cryo-EM structure
of the RNP of Ll.LtrB from Lactococcus lactis indicated
that the IEP bound as amonomer to a singleRNAmolecule
(20). RNPs can promote intron insertion into specific DNA
target sites (retrohoming) and at much lower frequency into
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sites resembling the normal intron site (ectopic transposi-
tion or retrotransposition). The RNP recognizes the target
site through both its IEP and RNA components, through
base-pairing to the target DNA (21,22). The RNA then
reverse splices into the top strand of the DNA target. In-
trons with En domain-containing IEPs use this domain to
cleave the bottom strand of the DNA target, generally 9
nt downstream from the insertion site. The 3′ end gener-
ated is used for target DNA-primed reverse transcription
(TPRT) of the inserted intron RNA (2,23). Once the cDNA
has been synthesized, various host factors complete intron
integration into the target site. These factors mediate the
degradation of intron RNA, intron second-strand synthe-
sis, the removal of DNA overhangs and ligation (24–27).
The screening of a battery of Escherichia colimutants iden-
tified several enzymes with effects on intron mobility (24),
such as RNases I and E, which are capable of degrading in-
tron RNA, and exonuclease III (XthA), which may degrade
the cDNA.RNaseH1 and Pol Imay be involved in the elim-
ination of the intron RNA after reverse transcription, and
DNA polymerases involved in replication and repair, such
as mutD (Pol III) and Pol II, IV and V, seem to be involved
in second-strand DNA synthesis.
Introns with IEPs devoid of En domains, such as the
RmInt1 intron of Sinorhizobium meliloti, cannot cut the
bottom strand of the DNA during retrohoming. Their
retrotransposition is linked to host replication, as they use
the nascent lagging strand at DNA replication forks (RNA
primers or Okazaki fragments) to prime reverse transcrip-
tion (28). The genes encoding the host factors required for
the retrohoming of En- introns have also been identified
(29). They encode proteins involved in DNA processing
(xthA4, radA and dnaK), RNA processing (rne and rnhB)
and Mg2+ transport (corA1). The only gene from this list
that seems to be required for efficient RmInt1 retrohoming
is xthA4.Mutations of any of the other genes leads to higher
rates of retrohoming.
RmInt1 displays a bias for retrohoming into the lagging
strand template during chromosome replication, probably
because these introns reverse splice into the transient ss-
DNA at DNA replication forks, raising questions about
possible interactions between RmInt1 RNPs and host fac-
tors, particularly the host replication machinery (30). Such
interactions have been described for other mobile genetic
elements, such as the Tn7 transposon and several inser-
tion sequences (IS) (31,32). Tn7 uses two pathways to se-
lect its target site. In one of these pathways, a sequence-
specific DNA-binding protein directs transposition into a
single site within the bacterial chromosome. In the other, a
transposon-encoded TnsE protein interacts physically with
the -sliding clamp of the DNA replication machinery (31).
Transposases from many IS families displaying an orien-
tation bias with respect to chromosomal DNA replication
have been shown to interact with the -sliding clamp (32).
In this study, we investigated the host factors capable of
physical interaction with the RmInt1 RNPs that might ac-
count for the DNA strand orientation bias displayed by this
intron during retrohoming.
MATERIALS AND METHODS
Bacterial strains, media and growth conditions
Sinorhizobium meliloti strain RMO17 (RmInt1 intron-less
strain) was grown at 28◦C on TY or defined minimal
medium (MM) (33). The E. coli DH5 strain was used for
the cloning and maintenance of plasmid constructs. The
Rosetta-gami (DE3) pLysS strain was used for protein pro-
duction. Escherichia coli strains were routinely grown at
37◦C on Luria-Bertani (LB) medium (34). Antibiotics were
added to the medium as required, at the following concen-
trations: kanamycin at 200 g/ml for S. meliloti and at 50
g/ml for E. coli, ampicillin at 200 g/ml, tetracycline at
10 g/ml and gentamicin at 50 g/ml for S. meliloti and 10
g/ml for E. coli.
Plasmid constructs
For the construction of pMalFlagIEP, a NotI fragment
containing the IEP tagged with 3xFlag was obtained by
the NotI digestion of pCEP4FlagIEP (35) and inserted
into the pMAL-c5X vector (New England Biolabs) di-
gested with NotI enzyme and dephosphorylated. We ob-
tained pMALFlagIEPORF in a similarmanner, but using
a NotI fragment from pCEP4FlagIEPORF (35).
pGmS4S2095-Fmal is a derivative of pGmS4S2095 (36)
in which the IEP has been replaced by the fusion pro-
tein MBP-FlagIEP (MF-IEP) sequence in the form of
a SpeI-AatII fragment from pMALFlagIEP. pGmS4S-
Fmal is a derivative of pGmS4S (36) in which the IEP
has been replaced by the MF-IEP sequence as a SpeI-
AatII fragment from pMALFlagIEP. This plasmid pro-
duces the fusion protein MF-IEP and the ORF of
RmInt1, under the control of the Sym promoter. pGmS-
Fmal was constructed from pGmS4S-Fmal by digestion
with NdeI and AvrII to remove the FlagIEP and ORF.
Flag was then added back to the plasmid as a poly-
merase chain reaction (PCR) fragment amplified with the
oligomers 5′-ACAAGGATGACGATGACAAGACTATA
GGCCAATTCGCCCTATA-3′ (GmS-Flg) and CTTGTC
ATCGTCATCCTTGT (GmS4S-Flg)
For the construction of p16N, dnaN was amplified from
S. meliloti RMO17 by PCR with the primers FwdnaN (5′-
CTCATATGCGTATTACTCTCGAGCG-3′) and Rvd-
naN (5′-CTGGATCCTTACACGCGCATCGGCATCA-
3′). The amplicon was inserted into the pGEMT-easy
vector (Promega) and sequenced. It was then inserted into
pET16b (Novagen) as an NdeI/BamHI fragment, to form
p16N.
Retrohoming assays in Sinorhizobium meliloti RMO17
Retrohoming assays were performed as previously de-
scribed (36). We used pGmS4S2095-Fmal, which expresses
the fusion protein MF-IEP and a retargeted RmInt1-
ORF flanked by short exons (−20/+5) under the control
of pSyn promoter, as a control in assays of the biological
activity of IEP mutants. All the mutants tested were deriva-
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RT activity assay
Reverse transcriptase activity was assayed with poly(rA)-
oligo(dT)18 as follows: 1 g protein was added to 10 l
of reaction mixture (50 mM Tris–HCl pH 7.5, 10 mM
KCl, 25 mMMgCl2, 5 mM 1.4-Dithiothreitol (DTT)) with
1 g poly(rA)-oligo(dT)18 or poly(rA), and 5 Ci of [-
32P]dTTP (800 Ci/mmol; Perkin Elmer). The reaction mix-
ture was incubated for 10 min at 37◦C, and 8 l of reac-
tion product was then spotted onto Whatman DE81 filters,
washed four times (5 min each) with 2× Saline SodiumCit-
rate (SSC) and counted in a Liquid Scintillation Analyser
(Beckman-Coulter).
LC-MS/MS and protein identification
MS analysis was performed at the Proteomics Service
of the Instituto de Parasitologı´a y Biomedicina ‘Lo´pez-
Neyra’ (CSIC, Granada). Protein samples were subjected to
sodium dodecyl sulphate-polyacrylamide gelelectrophore-
sis (SDS-PAGE) in a 4% acrylamide gel for 10 min. The
gel lane was cut into 10 slices and subjected to in-gel tryp-
tic manual digestion. The resulting peptides were fraction-
ated with an Easy n-LC II chromatography system (Prox-
eon) in line with an Amazon Speed ETD mass spectrom-
eter (Bruker Daltonics). In brief, peptides in 0.1% formic
acid and 3% acetonitrile were injected onto an EASY trap
column (2 cm, ID100 m, 5 m, C18; Thermo Fisher Sci-
entific). After washing with 0.1% (v/v) formic acid, peptides
were resolved on an Acclaim PepMap100, 15 cm × 75 m,
3m, 100A, C18 reverse-phase analytical column (Thermo
Fisher Scientific) over a 120 min organic gradient from 5 to
40% B with six gradient segments (5–40% solvent B over
120 min, 40–90% B over 5 min, 90–100% B over 2 min, held
at 100% B for 10 min and then reduced to 0% B over 1 min
and held at 0% for 2 min) with a flow rate of 300 nl.min−1.
Solvent A was 0.1% formic acid in water and solvent B was
0.1% formic acid in acetonitrile.
Peptides were ionized by a CaptiveSpray Ion Source
(Bruker Daltonics) at 1300 V. Tandem mass spectra were
acquired with an Amazon Speed ETD Ion Trap mass spec-
trometer controlled by TrapControl software v7.2 (Bruker-
Daltonics), operated in AutoMS acquisition mode. The ion
trap was set to analyse the survey scans in the mass range
m/z 400–1400 in Enhanced Resolution MS mode and the
top ten multiply charged ions in each duty cycle were se-
lected for MS/MS in UltraScan MS/MS mode. Fragmen-
tation conditions in the Amazon were as follows: exclusion
of simply charged ions, active exclusion after two spectra
and active release time of 0.5 min, threshold Absolute 20
000 and MS/MS fragmentation amplitude 60%. The raw
data files were processed with DataAnalysis software v4.3
(Bruker Daltonics) and used to search the UniProtTrembl
database with Mascot 2.4 (Matrix Science) and Protein-
Scape v4.0 (Bruker Daltonics). Peptide precursor mass tol-
erance was set at 0.5 Da, and MS/MS tolerance was set at
0.5 Da. The search criteria included carbamidomethylation
of cysteine (+57.02 Da) as a fixed modification and oxida-
tion of methionine (+15.99 Da) as a variable modification.
Searches were performed with a maximum of two missed
cleavages for tryptic digestion. The reverse database search
option was enabled and all peptide data were filtered to en-
sure a false discovery rate (FDR) ≤ 2%.
FLAG immunoprecipitation
We harvested 200 ml of bacterial culture with an OD600 of
0.6. The cells were collected by centrifugation and the pellet
was washed once with 24 ml of 0.1% sarkosyl in TE buffer
and twice with 20 mM Tris–HCl pH 7.4, 200 mM NaCl, 1
mM ethylenediaminetetraacetic acid (EDTA), 1 mM DTT.
The cells were again collected by centrifugation, and the re-
sulting pellet was resuspended in 8ml of lysis buffer (50mM
Tris–HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Tri-
ton X-100) plus proteinase inhibitors and incubated for 30
min at 4◦C with gentle shaking. Cells were lysed by sonica-
tion, with three pulses of 10 s each, and centrifuged at 12
000 × g for 10 min at 4◦C. The pellet was discarded and
100 l of Anti-FLAG M2-Agarose Affinity Gel (prepared
according to the manufacturer’s instructions) was added to
the supernatant, which was then incubated overnight at 4◦C
with gentle shaking. Samples were then centrifuged for 30
s at 8200 × g and the supernatant was discarded. The resin
was washed three times with 0.5 ml of wash buffer (50 mM
Tris–HCl, pH 7.4, 150mMNaCl). For elution, the resin was
incubated with 100 l of wash buffer supplemented with
150 ng/l of 3× Flag peptide for 30 min at 4◦C with gentle
shaking, and then centrifuged at 8200× g. The supernatant
containing the proteins was stored at −20◦C.
For Flag immunoprecipitation, we mixed 15 l of RNPs
with 185 l of lysis buffer and 30 l of ANTI-FLAG M2-
Agarose Affinity Gel and incubated the mixture for 2 h at
4◦C with gentle shaking. Negative controls were treated in
the same way, but with 15 l of Milli-Q water replacing
the RNPs. After incubation, samples were centrifuged for
30 s at 8200 × g and the supernatant was discarded. The
resin was washed three times with 0.5 ml of wash buffer and
incubated again in 0.5 ml of lysis buffer containing 8 g
of His-DnaN for 2 h at 4◦C, with gentle shaking. Samples
were washed five times with wash buffer. Proteins bound to
ANTI-FLAG-M2-Agarose were eluted with 100 l of wash
buffer supplemented with 150 g/l 3× Flag peptide for 30
min at 4◦C, with gentle shaking.
Pulldown assays
Rosetta-gami (DE3) pLysS cells were used to produce the
proteins for the assays. Cells were grown in LB supple-
mented with 0.2% glucose plus appropriate antibiotics at
37◦C until an OD600 of 0.5 was attained. They were then in-
duced with 0.2 mM isopropyl--D-thiogalactopyranoside
(IPTG) and cultured at 18◦C overnight. Aliquots (2 ml)
were centrifuged and the pellets were resuspended in 1 ml
of buffer (50 mM Tris–HCl pH 6.8, 100 mMNaCl, 10 mM
CaCl2 and proteinase inhibitors for proteins containing a
His tag, or 20 mM Tris–HCl pH 7.4, 200 mMNaCl, 1 mM
EDTA, 1 mM DTT and proteinase inhibitors for MBP fu-
sions) and incubated on ice for 30 min. Samples were son-
icated with three pulses of 10 s each, and were then cen-
trifuged at 12 000 × g for 15 min at 4◦C. For MBP fusion
proteins, 80 l of amylose resin was added to the super-
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was washed three times with the buffer used to resuspend
the MBP fusion proteins and was then added to the super-
natant ofHis-tagged proteins, and the resultingmixture was
incubated for 3 h at 4◦Cwith gentle shaking. During this in-
cubation, 100 units of RNase A/T1 were added to the mix-
ture for the RNase-treated sample. The resin was washed
four times and resuspended in 100 l of SDS sample buffer.
The binding of His-tagged proteins toMBP-fusion proteins
was assessed by western blotting with horseradish peroxi-
dase (HRP)-conjugated anti-His antibodies.
Peptide binding assay
Assays were performed in a volume of 50 l, with 700 g
of streptavidin-coated magnetic beads (Sigma Aldrich) in
50 mM Tris–HCl, 100 mM NaCl, 5% glycerol, pH 7.5. We
mixed 440 M biotinylated peptides with the beads, which
were then incubated for 30 min and washed three times. We
then added His-tagged DnaN (4 M), incubated 10 min
and washed the beads four times with the same buffer. Re-
actions were stopped by adding 1% SDS and the reaction
mixture was subjected to SDS-PAGE and western blotting
with anti-His tag antibodies. Signals were detected with a
ChemiDoc system and quantified with Quantity One soft-
ware (Bio-Rad).
Western and far-western blotting
Western blots were performedwith an ECL kit (GEHealth-
care), according to the manufacturer’s instructions. Mem-
braneswere blockedwith a blocking solution containing 3%
skimmed milk powder. Antibodies were used at the follow-
ing dilutions: monoclonal HRP-conjugated anti-polyHis
1:200000 (SigmaA7058); anti-Flag 1:100000 (SigmaF1804)
and anti-mouse IgG-HRP conjugate 1:250000 (Sigma
A9044).
Far-western blots were performed as described elsewhere
(37). We subjected lysates (10 g of total protein) of
Rosetta-gami (DE3) pLysS cells expressing the fusion pro-
tein MBP-FlagIEP from pMALFlagIEP to SDS-PAGE,
and the resulting bands were blotted onto PVDF (GE
Healthcare) membranes. The proteins were denatured and
renatured on the membranes in AC buffer (100 mM NaCl,
20 mM Tris (pH 7.6), 0.5 mM EDTA, 10% glycerol, 0.1%
Tween-20, 2% skimmed milk powder and 1 mM DTT), by
gradually decreasing the concentration of guanidine-HCl.
The membrane was incubated in AC buffer containing 6
M guanidine-HCl for 30 min at room temperature, and
then with AC buffer containing 3 M guanidine-HCl for 30
min at room temperature, followed by AC buffer plus 1 M
guanidine-HCl and two incubations with AC buffer con-
taining 0.1 M guanidine-HCl and no guanidine-HCl AC,
both at 4◦C, for 30 min and 1 h, respectively. The mem-
brane was then blocked by incubation with 5% skimmed
milk powder in PBST for 1 h at room temperature. The
membrane was incubated with His-DnaN (total 5 g, 1
g.ml-1) in buffer (100 mM NaCl, 20 mM Tris (pH 7.6),
0.5 mMEDTA, 10% glycerol, 0.1% Tween-20, 2% skimmed
milk powder and 1 mM DTT) for 2 h at room tempera-
ture. The unbound protein was removed by three washes in
PBST, for 10 min each. The membrane was then incubated
with monoclonal HRP-conjugated anti-polyHis- antibod-
ies (1:200000) (Sigma A7058) in 3% skimmed milk powder
in PBST buffer for 1 h at room temperature. It was then
washed six times, for 5 min each, with PBST buffer and
chemiluminescence detection was performed with an ECL
kit (GE Healthcare), according to the manufacturer’s in-
structions
Protein purification
MF-IEP and the mutants generated were purified as fol-
lows: pMalFlagIEP or mutants derived from this plasmid
were used to transform Rosetta-gami (DE3) pLysS cells,
which were cultured to an optical density (OD600) of 0.5
at 37◦C in 1 l of LB medium supplemented with chloram-
phenicol (50 g/ml), ampicillin (100 g/ml) and 0.2% glu-
cose. Protein production was then induced by adding IPTG
to a final concentration of 0.3 mM and incubating at 20◦C
overnight. Bacterial cells were harvested by centrifugation
at 5000 × g for 15 min at 4◦C and resuspended in 25 ml
of binding buffer (20 mM Tris–HCl, 200 mM NaCl, 1 mM
EDTA, 1 mMDTT pH 7.4). They were then lysed by three
passages through a 1000 PSIG French press and the result-
ing lysates were clarified by centrifugation at 38 000 × g for
1 h at 4◦C. The supernatant was applied to anMBPTrapHP
affinity column (GE Healthcare) equilibrated with bind-
ing buffer and washed with five column volumes. Proteins
were eluted with elution buffer (10 mM maltose in bind-
ing buffer) and subjected to SDS-PAGE. The eluate con-
taining the protein was dialysed against 20 mM Tris–HCl,
200 mMNaCl, 1 mMEDTA, 1 mMDTT, 10% glycerol pH
7.4 at 4◦C. Dialysed proteins were passed through a size ex-
clusion column HiLoad Superdex 75 equilibrated with the
same buffer used for dialysis and the peak corresponding to
monomer was collected and frozen at −80◦C.
For DnaN purification, the p16N plasmid was used to
transform Rosetta-gami (DE3) pLysS cells. The cells were
cultured to an OD600 of 0.5 in 1 l of LB medium supple-
mented with 100 g/ml ampicillin and 50 g/ml chloram-
phenicol at 37◦C. Protein production was induced at 20◦C,
by adding IPTG to a final concentration of 0.3 mM. Af-
ter 18–20 h of growth, the cells were harvested by centrifu-
gation at 5000 × g for 15 min at 4◦C. They were then re-
suspended in 25 ml of buffer A (25 mM sodium phosphate
buffer pH 7, 0.5 M NaCl, 5% glycerol) and lysed by three
passages through a 1000 PSIG French press. The lysate was
centrifuged at 38 000 x g for 1 h at 4◦C. The supernatant was
loaded onto a HisTrap™ HP 5 ml column (GE Healthcare)
equilibrated with buffer A, which was then washed with
three column volumes of the same buffer. The column was
then washed with three column volumes of 5% buffer B (25
mM sodium phosphate buffer pH 7, 0.5 M NaCl, 5% glyc-
erol and 1 M imidazole) in buffer A. Proteins were eluted
along a gradient running from 5% buffer B to 100% buffer
B over a period of 15 min. Fractions were subjected to SDS-
PAGE and those containing DnaN were pooled, dialysed
overnight against buffer D (50 mM Tris–HCl pH 8, 50 mM
NaCl, 1 mM EDTA, 1 mM dithiothreitol (DTT) and 10%
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Biolayer interferometry
The association (kon) and dissociation (koff) rate constants
for -clamp binding to MF-IEP were determined with a
BLItz system (ForteBio, Pall, Spain) (38).The -clamp pro-
tein (at a concentration of 0.5 M) was immobilized on
His-tagged biosensors (Forte Bio) previously hydrated with
10× kinetic sample buffer (ForteBio, the 10× kinetic sam-
ple buffer as supplied by the manufacturer consisted of 10
mM sodium phosphate, 150 mM NaCl, Tween 20 (0.02%),
albumin (0.1%) and sodium azide (0.05%) at pH 7.4). Vari-
ous amounts of MF-IEP protein (typically 0.5, 1, 1.5, 2 and
3 M) were used in the association steps. The response was
monitored every 0.2 s. Each sensorgramwas compared with
the reference signal obtained for buffer alone at the start of
each experiment.
The general scheme for association/dissociation reac-
tions for both proteins was: 30 s of initial baseline condi-
tions with the 10× kinetic buffer; 120 (or 240) s ofDnaN (-
clamp) protein loading onto the biosensor; 30 s of baseline
with 10× kinetics buffer; 120 (or 240) s of MF-IEPs (MF-
IEP, or mutants MF-IEP104 and MF-IEP108) association
with the biosensor (previously loaded with -clamp); and
120 (or 240) s of MF-IEP dissociation from the biosensor.
The interferometric response during the association step,
R(t) (measured in resonance units, RU) and used to eval-
uate the kinetics of the DnaN-MF-IEP interaction is given
by: R(t) = Req − Req × exp(− kobs ×(t − 120)), where Req is
the steady-state, or equilibrium, response obtained at infi-
nite time. The number 120 (or 240) in the equation above
corresponds to the time when the association step between
DnaN-biosensor-bound and MF-IEP in the solution be-
gins (see above). As experimental conditions correspond to
a pseudo-first-order regime, the value of the kobs is given
by: kobs= kon × [MF-IEP]+ koff, where kon (M-1 s-1) and
koff (s-1) are the association and dissociation rate constants
of the binding reaction, and [MF-IEP] is the concentra-
tion of the protein (wild-type or mutants) in the solution.
From the values of kon (M-1 s-1) and koff (s-1), we thus ob-
tained an apparent equilibrium association constant, KA,
such that KA = kon/koff. Kinetic curves describing the asso-
ciation step between MF-IEP and DnaN-biosensor-bound
were initially fitted to the sensorgrams with BLItz Pro ver-
sion 1.2 software provided by the manufacturer, using a sin-
gle exponential curve. Successively, to further improve the
residuals of the fittings of the sensorgrams, we employed
the software Kaleidagraph (Synergy software) and anal-
ysed data at all MF-IEP concentrations, using two expo-
nential curves: R(t) = Req −Raeq × exp(− kobs ×(t − 120)) −
Rbeq × exp(−k′obs × (t − 120)); with this equation we are as-
suming that the equilibrium response, Req, is attained with
the fastest kobs. Furthermore, the use of this equation indi-
cates that the binding betweenMF-IEP andDnaN does not
follow a simple kinetic 1:1 model. Fittings using Kaleida-
graph had, in all sensorgrams, regression coefficients larger
than 0.999 and the residuals did not show any tendency. The
uncertainty in the reported kobs at each concentration is the
fitting error to the double exponential equation. Finally, we
note that in interferometry, a ‘jump’ (discontinuity) may oc-
cur between the response units at the start of the association
or dissociation step. These jumps are due to the changes in
the refractive index detected by the biosensor (39) at the be-
ginning of these steps. Such discontinuities are taken into
account by themanufacturer’s software during curve fitting.
Control experiments were also carried out with MF alone,
in the same range of concentrations as used for theMF-IEP
protein.
Sequence and structural alignments
Structure-based sequence alignments were generated with
T-COFFEE (40), as previously described (41). Structural
alignments were generated manually in Coot, with the
secondary structure matching algorithm (42). The fig-
ures depicting the structures were drawn with PyMOL
(The PyMOL Molecular Graphics System, Version 2.0
Schro¨dinger, LLC).
Reconstitution of RmInt1 RNP particles in vitro
RmInt1-ORF RNP particles were reconstituted from in
vitro-synthesized, gel-purifiedRmInt1-ORFprecursor in-
tron RNA (908 nt) and amylose affinity-purified MF-IEP,
as previously described (43). Briefly, 350 nM precursor in-
tron RNA in 80 mMMOPS pH 7.5 was denatured by heat-
ing at 90◦C for 2 min and then renatured by incubation at
50◦C for 2 min, followed by slow cooling at room tempera-
ture for 1 min. A self-splicing reaction was induced at 50◦C
by adding 500 mM NH4Cl and 100 mMMgCl2. After 5 h,
3.5 M purified MF-IEP protein was added to the spliced
RNA and the resulting complexes were incubated at 30◦C
for 2 h. The ribonucleoprotein particles (RNPs) were di-
luted in 450 mMNaCl, 5 mMMgCl2, 40 mMTris–HCl pH
7.5 buffer and pelleted by ultracentrifugation in a Beckman
50 Ti rotor at 50 000 rpm for 18 h at 4◦C. Finally, the RNP
preparations were kept in 5 mM Tris–HCl pH 7.5, 0.5 mM
DTT, 50% glycerol at −80◦C. The sedimentation process
was monitored by collecting fractions along the tube vol-
ume. Fractions were desalted and concentrated with Am-
icon YM-30 filter units. The protein content of each frac-
tion and the pellet was evaluated bywestern blottingwith an
anti-FLAG primary antibody. The presence of intron RNA
was demonstrated by primer extension and the resolution
of products on electrophoresis in 6% polyacrylamide gels.
RESULTS
Functionality of the RmInt1 IEP fusion protein
Like other group II intron-encoded proteins, the RmInt1
IEP has a very high isoelectric point (9.83), resulting in low
solubility (44). We fused a 3xFlag N-terminally tagged IEP
to the C-terminal part of maltose binding protein (MBP)
to facilitate purification and increase RmInt1 IEP solu-
bility (44). We first assessed the functionality of the fu-
sion (MBP-Flag-IEP) protein (hereafter referred as to MF-
IEP) in retrohoming, by comparing intron insertion fre-
quencies between the intron donor plasmid, pGmS4S2095,
which expresses a wild-type IEP, and a retargeted RmInt1-
ORF flanked by short exons (−20/+5) under the control
of the Psyn promoter, with an equivalent intron construc-
tion (pGmS4S2095-Fmal) but harbouring the IEP fusion
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Table 1. RmInt1 RNP proteins identified by Flag immunoprecipitation
Protein Score #Peptides SC(%)
DNA polymerase III subunit beta
(DnaN)
280.72 5 14.80
Ribosomal protein S2 111.01 3 13.3
S-adenosylmethionine synthetase 85.55 2 6.10
Heat-shock protein Hsp20 72.89 2 13.7
SC: sequence coverage.
lacZ antisense strand in nucleotide position 2095 (2095as)
on the lagging template strand (LAG) (36). Retrohoming
assays were performed in S. meliloti strain RMO17, with
a lacZ gene inserted close to the chromosomal origin of
replication (36). The plasmid carrying MF-IEP displayed
51% the level of retrohoming displayed by the wild-type IEP
(Figure 1). The MF-IEP is, thus, a functional protein, and
can be used to identify the host proteins interacting with
RmInt1 RNPs.
Identification of proteins interacting with RmInt1 RNPs
Lysates ofS.meliloti cells harbouring the intron donor plas-
mid, pGmS4S-Fmal, which expresses the MF-IEP, and the
wild-type RmInt1-ORF, or the negative control, pGmS-
Fmal, which expresses only the MBP-Flag (MF) protein,
were subjected to immunoprecipitation with an anti-Flag
antibody. Lariat intron RNA was detected in the eluted
fraction of cells harbouring pGmS4S-Fmal, but not in that
of cells harbouring the control plasmid. The cells har-
bouring pGmS4S-Fmal therefore produced RmInt1 RNPs.
The proteins in the eluted complex were analysed by liq-
uid chromatography-tandem mass spectrometry (MS), and
were identified with a false discovery rate (FDR) <2% and
with at least two peptides (Table 1). Interestingly, DnaN
(also call -sliding clamp), a component of DNA poly-
merase III involved in DNA replication, was detected only
in the eluted complexes from cells harbouring pGmS4S-
Fmal.We explored this interaction further, as we considered
it potentially relevant for mediating the putative association
of RmInt1 with the host DNA replication machinery.
RmInt1 IEP interacts with DnaN
We investigated the possible interaction of RmInt1 RNPs
with DnaN using three different techniques: MBP pull-
down assays, far-western blotting and biolayer interferom-
etry. For pulldown assays, the culture supernatants of E.
coli cells overexpressing the MF-IEP and RmInt1 ORF
(pMalFlagIEPORF) or just the fusion protein MF-IEP
(pMalFlagIEP) were assayed against the supernatants of
cells overexpressing His-tagged S. meliloti DnaN (p16N).
DnaN was present in both samples (Figure 2A), but not
in the control (supernatants of cells overexpressing only
the MBP-Flag protein (MF)), suggesting that DnaN and
RmInt1 RNPs may interact via the IEP component. We en-
sured that no endogenous group II intron RNAwas associ-
ated with the MF-IEP (pMalFlagIEP) expressed in E. coli,
by performing a pulldown assay including RNase A/T1
treatment during the incubation of resin-bound MF-IEP
Figure 1. In vivo intron mobility assay. (A) Schematic of the assay show-
ing intron donor plasmids (pGmS4S2095Fmal and pGmS4S2095), recipi-
ent lacZ gene and retrohoming product. LAG denotes that lagging strand
DNA is used as primer for reverse transcription of the inserted intron
RNA. In the lacZ gene the intron insertion site is shown (2095as). Psyn,
syn promoter; EBS1,2,3, exon binding sites modified to recognize target
2095as into lacZ gene; E1, E2 short exons −20/+5; MF-IEP (MBP-Flag-
IEP protein); IEP (wt IEP). (B) Comparison of retrohoming efficiencies
between an intron expressing the wt IEP and the same intron expressing
the MF-IEP fusion protein. Results are expressed as percentage of white
colonies. Error bars are standard deviations (SDs) of three experiments.
with DnaN. In this sample, DnaN was also recovered, pro-
viding further support for the notion that the interaction
involves the IEP component of the RNPs (Figure 2A). The
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Figure 2. Interaction of the RmInt1 IEP with DnaN. (A) Pulldown assays ofMF-IEP without theORF ribozyme of RmInt1 (MF-IEP),MF-IEP treated
with RNase A/T1 (MF-IEP +RNase), MF-IEP and RmInt1ORF ribozyme (IEP+ORF), andMBP fused to the Flag epitope (MF) as a control. Note
that theMBP andMFproteins behave similarly. All protein samples were assayed against supernatants containingHis-taggedSinorhizobiummelilotiDnaN.
The proteins retained were subjected to SDS-PAGE and stained with Coomassie blue (Coomassie), and a western blot was performed with antibodies
against the His tag (western), demonstrating the presence of His-tagged DnaN. (B) Far-western blot. Total protein (10 g) from cells overproducing MF-
IEP (MF-IEP) or MBP (control) was subjected to SDS-PAGE and stained with Coomassie blue (Coomassie) or subjected to far western blotting with
His-tagged DnaN replacing the primary antibody and detection with antibodies against the His-tag, revealing the presence of His-tagged DnaN at the
same molecular weight asMF-IEP. (C) Binding of biosensor-boundDnaN toMF-IEP. Biolayer interferometry results for theMF-IEP fusion protein (top)
and for MF (bottom). (D) Flag immunoprecipitation of active RNPs containing the MF-IEP protein. His-DnaN was recovered in the immunopreciptate
obtained with anti-Flag antibodies only when RNPs were used (RNPs). No His-DnaN was retained by the anti-Flag antibodies (Beads).
far-western blotting (Figure 2B), with the detection of a
specific signal for His-DnaN at the same molecular weight
as the MF-IEP. Consistent with these results, biolayer in-
terferometry (Figure 2C) showed that the MF-IEP binds
DnaN with an apparent affinity of 0.4 ± 0.2 M, assum-
ing a 1:1 kinetic pathway. The binding of the MF-IEP in
solution (from 300 to 540 s) to the biosensor loaded with
His-tagged DnaN, and its dissociation from the biosensor-
bound -clamp (from 540 to 780 s) following biosensor im-
mersion in a solution containing only the buffer was demon-
strated by the exponential behaviour of the curves obtained
at increasing amounts ofMF-IEP used (Figure 2C). By con-
trast, the control MF protein displayed no significant bind-
ing to the biosensor-bound DnaN. Together, these results
indicate that the RmInt1 IEP binds to the DnaN protein.
We then investigated whether active RNPs interact with
DnaN using in vitro reconstituted RNPs in Flag immuno-
precipitation assays. Active RmInt1-ORF RNP particles
were reconstituted from precursor intron RNA synthesized
in vitro and purified MF-IEP, as previously described (43).
The presence ofMF-IEP and intron lariat RNA in the RNP
pellet was confirmed by primer extension and western blot-
ting, and the functionality of these elements was assessed
in endonuclease activity assays (Supplementary Figure S1).
The reconstituted RNPs were bound to anti-FLAG-M2
affinity gel and purified His-DnaN was added. As a nega-
tive control, anti-FLAG-M2 affinity gel without RNPs was
also mixed with His-DnaN. After incubation and washing,
the immunoprecipitated Flag-taggedproteins were analysed
by western blotting with anti-His antibodies. DnaN was re-
covered in the RNP sample, with no signal detected for the
control (Figure 2D). These results further indicate that ac-
tive RmInt1 RNPs interact with DnaN.
Identifying a possible DnaN binding motif of the RmInt1 IEP
We fused three different overlapping fragments of the IEP
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Figure 3. Pulldown assay performed with DnaN and various fragments of
the RmInt1 IEP and peptides. (A) Diagram of the various parts of the IEP
used in pulldown assays (lower panel). N, N-terminal part of IEP;M, mid-
dle region of IEP; C, C-terminal part of IEP; control, MBP. IEP domains
are also shown; RT, reverse transcriptase domain with conserved RT se-
quence blocks (0-7); X, maturase domain; *, C-terminal tail. The positions
of the peptides used in panel (B) are also shown. Bottom panel, pulldown
assay performed with His-DnaN and various fragments of IEP. The pro-
teins retained were subjected to SDS-PAGE and stained with Coomassie
blue (Coomassie) or subjected to western blotting (western) with antibod-
ies against the His-tag, revealing the presence of His-tagged DnaN in lanes
N and M. (B) Peptide binding assay. Sequences of peptides from IEP and
DNA polymerase IV used in the assays. Pol IV* has the same sequence as
Pol IV except that the two residues underlined in the Pol IV sequence are
replaced with alanines. The binding levels are expressed as a percentage
relative to the amount of His-tagged DnaN retained by the Pol IV peptide
(dashed line). (C) Peptide binding assay with mutant peptides. Sequences
of the peptides synthesized, in which the underlined residues of peptide
1-1 have been replace with alanines. Peptides were coupled to streptavidin-
coated paramagnetic beads and used to retainHis-taggedDnaN.The bind-
ing levels are expressed as a percentage relative to the amount ofHis-tagged
DnaN retained by peptide 1-1 (dashed line). In panels B and C, error bars
represent standard error of the mean determined from three independent
experiments.
says, to identify the part of the RmInt1 IEP responsible for
interaction with DnaN (Figure 3A). These assays suggested
that the putative binding region was probably present in the
RT domain (RT2 to RT4) common to the N and M frag-
ments of the IEP, because the C-terminal part of the protein
did not appear to interact with DnaN.
Many proteins interacting with DnaN harbour a
QLS/DLF binding motif (45), but this motif is poorly
conserved and absent from a number of DnaN-interacting
proteins. TnsE, a protein encoded by the Tn7 transpo-
son, interacts withDnaN through the QLELARALFLmo-
tif (31). A similar motif, QMIEPDLDSLFL, is present in
the C-terminal region of the RT2 domain of RmInt1IEP.
We explored the region of the IEP binding to DnaN in
more detail, by synthesizing four 20-amino-acid-long N-
biotinylated peptides (Figure 3B). Peptides 1-0 and 1-3
corresponded to the first and last 20 amino acids, re-
spectively, of the IEP. These regions have a higher pre-
dicted level of intrinsic disorder (46). Peptide 1-1 contained
the QMIEPDLDSLFL motif, and peptide 1-2 contained
amino-acid residues (QLNPLL) from the maturase domain
resembling the DnaN-binding motif. The peptides were
bound to streptavidin magnetic beads, for assessment of
their ability to bind and retain His-tagged DnaN. As a pos-
itive control, we used a peptide derived from DNA poly-
merase IV (Pol IV). The negative control was the same pep-
tide with two amino acids replaced with alanine residues
(Pol IV*). The results are expressed as a percentage of the
amount of His-tagged DnaN retained by the Pol IV pep-
tide (Figure 3B). As expected, only peptide 1-1, carrying the
QMIEPDLDSLFL motif, bound to DnaN, with retention
rates 20% those for the control peptide.
We then synthesized a set of peptides similar to peptide 1-
1, but with selected amino acids of themotif replaced by ala-
nine residues. These peptides were used in pulldown assays
(Figure 3C). All of the positions substituted, with the excep-
tion of I100A and L109A, appeared to be involved in the
interaction, with L104A and F108A causing the strongest
decrease in DnaN-retaining capacity.
In order to see if mutations L104A and F108A affect the
interaction between DnaN and MF-IEP, we made mutants
MF-IEP104 and MF-IEP108 (MF-IEP carrying substitu-
tion L104A and F108A, respectively) and tried to provide a
quantitative measurement of the affinity between MF-IEP,
MF-IEP104 andMF-IEP108 with DnaN by biolayer inter-
ferometry. For all the explored concentrations, we carried
out the fitting of the association step of the sensorgrams
with a double exponential curve. These results indicate that
the binding between MF-IEP and DnaN does not follow
a simple 1:1 kinetic mechanism. The fastest rate, kobs, was
MF-IEP-concentration-dependent, while the other (slow-
est) rate was constant (with a value for the three species, at
any of the explored concentrations, of 0.006–0.008 s-1). The
pseudo-first order plots (Figure 4) for the fastest protein-
concentration-dependent kobs indicate that the kon for wild-
type MF-IEP was 0.082 ± 0.014 M-1 s-1, whereas those of
MF-IEP104 and MF-IEP108 were 0.044 ± 0.005 M-1 s-1
and 0.010 ± 0.007 M-1 s-1, respectively (as it can be easily
observed from the slopes in Figure 4). Therefore, assuming
the same koff for the three MF-IEP species (that is, the rate
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Figure 4. Pseudo-first order plots from biolayer interferometry for wild-
type MF-IEP (blank squares and dot-and-dashed blue line), MF-IEP104
(blank circles and continuous red line) and MF-IEP108 (filled circles and
dashed black line). The errors in kobs for each experimental MF-IEP
species concentration are from fitting errors of the sensorgrams to a double
exponential curve.
we can conclude that the wild-type species bind faster than
the other two mutants and with a larger apparent equilib-
rium association constant KA (that is, a larger affinity).
Analysis of the RmInt1 IEP DnaN binding motif in available
3D structures of IEPs
Structure-based sequence alignments of the RmInt1 IEP
with the IEP of Eubacterium rectale (PDB ID: 5HHL),
Roseburia intestinalis (PDB ID: 5HHJ), Geobacillus
stearothermophilus (PDB ID: 6AR1) (47) and L. lactis
LtrA (PDB ID: 5G2X) revealed that the QMxxxxLxxLFL
motif is structurally conserved (Supplementary Figure S2).
Moreover, in all available IEP 3D structures this motif
points towards the protein surface (Figure 5), with the most
solvent-exposed region corresponding to the C-terminal
amino acids of the motif (LxxLFL), including the RmInt1
L104 and F108 analogues. Part of this solvent-exposed
region forms a loop and adopts alternative conformations
in Eu.re.I2/Ro.in.IEP versus LtrA. In the crystal structure
of Eu.re.I2 (and correspondingly in the essentially identical
structure of Ro.in.IEP), Y102 (analogous to RmInt1 L104)
and F106 (analogous to RmInt1 F108) establish a network
of hydrogen bonds and hydrophobic interactions with
neighbouring residues located on the protein surface. In
the cryoEM structure of LtrA, the density of the LxxLFL
loop is not well defined suggesting flexibility, and Y122
(analogous to RmInt1 L104) and F126 (analogous to
RmInt1 F108) are loosely embedded in a hydrophobic
cage on the protein surface. Structural conservation of the
QMxxxxLxxLFL motif and its localization in a solvent
accessible region in all available structures suggest that the
Figure 5. Overall structure representation of IEPs. (A) Ll.LtrB RNP. (B)
Eu.re.I2. (C) Ro.in.IEP. (D) Ge.st.IEP. The surface of the IEP is depicted
in grey, the QMxxxxLxxLFL motif is in blue and the intron of Ll.LtrB is
in wheat colour.
ability to interact with DnaN may be a general feature of
group II intron IEPs.
Biological activities of RmInt1 IEP mutants
We assessed the importance of the interaction with DnaN
forRmInt1 retrohoming, by constructing differentMF-IEP
mutants with the same amino-acid substitutions as were
made for peptide 1-1. We analysed the retrohoming of the
mutants into the lacZ gene inserted into the chromosome
of S. meliloti strain RMO17 (36). Only four mutants (100,
104, 108 and 109) displayed retrohoming levels significantly
lower than those of the wild-type control (Figure 6A). The
104 and 108 mutants displayed the strongest impairment,
consistent with the biochemical and structural data. All
the mutants produced the MF-IEP fusion protein and dis-
played intron RNA splicing demonstrating the production
of active RNPs (Supplementary Figure S3). However, as-
says of RT activity revealed differences between themutants
(Figure 6B). As expected, given that the mutated amino
acids belonged to the RT2 and RT2a domains, all the mu-
tants had lower levels of RT activity than the wild-type. The
greatest impairment of RT activity was observed for mu-
tants 100, 104, 108 and 109. Despite this decrease in RT ac-
tivity, mutants 100 and 109 retained significant retrohoming
activity (10 and 15%wild-type levels, respectively). Interest-
ingly, the retrohoming impairment was stronger in mutants
104 and 108 (<5% wild-type levels). One possible explana-
tion for these results is that the lower levels of retrohom-
ing observed formutants 104 and 108 reflects their impaired
binding to DnaN.
DISCUSSION
We show here that the RmInt1 IEP interacts with DnaN (-
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Figure 6. Biological activities of IEP mutants. (A) MF-IEP mutants were
assayed for retrohoming into the lacZ gene inserted into the chromosome
of Sinorhizobium meliloti strain RMO17. The results are expressed as the
percentage of white colonies. The control is the wild-typeMF-IEP with no
amino-acid substitution. (B) In vitro RT activity of MF-IEP mutants.
the replication fork for target site selection and reverse splic-
ing into transient single-stranded DNA.
Using the Flag epitope for immunoprecipitation, we
identified a very small number of proteins that appeared
to interact with RmInt1 RNPs, including the ribosomal
protein S2, a component of the 30S ribosomal subunit, S-
adenosylmethionine synthetase and the Hsp20 heat-shock
protein. The RNA component of the RNP of the Ll.LtrB
intron has been reported to interact with ribosomes via
the 30S subunit (48,49), protecting the intron RNA against
RNase E cleavage. The nature of the interactions of the
other two proteins with the IEP remains to be clarified.
Interestingly, we also found that DnaN, a component of
DNA polymerase III, immunoprecipitated with the protein
(IEP) component of theRmInt1RNP. Pulldown assays, far-
western blots and interferometry all revealed a direct inter-
action between the RmInt1 IEP and the -sliding clamp.
The interaction likely involves a motif (QMxxxxLxxLFL)
more similar to that present in the TnsE domain of the Tn7
transposon than to the QLS/DLF motif present in the ma-
jority of-sliding clamp-interacting proteins. The apparent,
calculated KD (∼0.4 ∼M) was higher than the KD reported
for the interaction between the  subunit of the clamp
loader complex and the -clamp [∼0.03 M, (50)], suggest-
ing that the interaction with the IEP is weaker. This is not
particularly surprising, because the interaction of RmInt1
RNPs with the -clamp must not interfere with other inter-
actions required for its normal activity. Moreover, the puta-
tive binding region of the IEP is located in the N-terminal
part of the protein, whereas the binding regions of most
-sliding clamp-interacting proteins are located at the C-
terminal part of the protein.
The QMxxxxLxxLFL motif is structurally conserved in
group II intron En+ and En-IEPs. An analysis of available
IEP 3D structures and the localization of the amino acids
analogous to RmInt1 IEP L104 and F108 suggested two
hypotheses for the role of these residues in regulating intron
retrotransposition and, possibly, binding toDnaN. Accord-
ing to the first hypothesis, the analogues of L104/F108 are
rigid and confer structural integrity to theQMxxxxLxxLFL
motif (particularly to the LxxLFL loop portion), thereby
shaping the surface of the IEP to optimize the binding and
recognition of DnaN. This hypothesis is well supported by
the structures of Eu.re.I2 and Ro.in.IEP, which were de-
termined at high resolution (1.2–2.2 A˚) by X-ray crystal-
lography with a truncated IEP in the absence of the cog-
nate intron. According to the second hypothesis, the ana-
logues of L104/F108 are dynamic and toggle between a
solvent-protected conformation (mimicked by the Eu.re.I2
and Ro.in.IEP structures) and a solvent-exposed conforma-
tion (mimicked by the LtrA structure), which brings these
residues to the surface of the IEP, rendering their side-
chains available for direct binding toDnaN. This hypothesis
is suggested by the conformation of LxxLFL in LtrA, the
structure of which was solved at medium resolution (3.8 A˚)
by cryoelectron microscopy with the full-length IEP bound
to the cognate intron. For both these hypotheses, the delete-
rious effect of L104A and F108A on intron retrotransposi-
tion can be attributed to localized structural distortions of
the QMxxxxLxxLFL motif caused by the mutations. The
mutations are unlikely to cause the complete misfolding of
the IEP, because the QMxxxxLxxLFL motif is peripheral
and because we have confirmed that the mutant RNPs re-
tain their splicing capacity.
All mutations of this binding motif decrease RT activity,
but the Q98A, M99A and L107A mutants have retrohom-
ing levels similar to that of the wild-type control, suggesting
that this decrease in RT activity in vitro is overcome byRNP
formation in vivo. A similar situation seems to occur for the
I100A and L109A mutants, which have strongly impaired
RT activity but which retain 10–15% of wild-type rehom-
ing activity in vivo, these lower levels of retrohoming being
attributable to the impairment of RT activity. Mutants 104
and 108 also displayed a strong impairment of RT activ-
ity and their retrohoming levels were the lowest observed
among the mutants, possibly due to their lack of interac-
tion with the g that the intera-clamp, the positions affected
in these mutants being the most likely to play a significant
role in the interaction (Figure 3C). TheQMxxxxLxxLFmo-
tif thus appears to mediate the interaction of RmInt1 IEP
with DnaN.
We hypothesized that RmInt1 localizes at ssDNA sites







niversidad de Zaragoza. Biblioteca U
niversitaria user on 24 O
ctober 2019
Nucleic Acids Research, 2019, Vol. 47, No. 14 7615
Figure 7. Possible model for mobility of group II introns displaying a replication orientation bias. A1 and A2 represent the pathway used by RmInt1 (En-
intron) and probably for the retrotransposition of En+ introns, which show a bias for insertion into the lagging strand template. They localize to ssDNA
by interacting with g that the intera-clamp; it could take place with stalled replication forks, during the shifting between different host-encoded DNA
polymerases or with the DnaN that remains bound to DNA in the lagging strand behind the replication fork (A1) and then reverse splice into its ssDNA
target site (A2); DNA polymerase would disengage upon encountering the highly structured intron or tightly bound IEP, leaving the nascent DNA strand
in position to be used as a primer by the IEP to reverse transcribe the inserted intron RNA. A host DNA polymerase probably resumes DNA synthesis
after reverse transcription of the intron RNA. (B) It represents the pathway used bymutants of En+ introns lacking endonuclease activity and displaying an
orientation replication bias toward use of the nascent leading strand DNA as a primer for reverse transcription of the inserted intron RNA. After reverse
splicing into the leading strand template without cleavage of the opposite strand, the intron RNP is in a position to use the nascent leading strand from
an approaching replication fork as a primer.
interaction that should not interfere with other processes
where DnaN is required. For example, it could take place
with stalled replication forks during shifting between dif-
ferent host-encoded DNA polymerases, or with the DnaN
that remains bound to DNA in the lagging strand behind
the replication fork (Figure 7A1). We speculate that the lat-
ter situation might arise due to slow recycling after Okazaki
fragment synthesis (51,52). RNP then reverse splicing into
the target in its ssDNA form (Figure 7A2). The IEP then
uses the nascent lagging DNA strand for reverse transcrip-
tion of the intron RNA. It is possible to speculate that host
DNA polymerase disengages upon encountering the highly
structured intron or tightly bound IEP, leaving the nascent
DNA strand in position to be used as a primer by the IEP.
In this context, a host DNA polymerase would likely re-
sume DNA synthesis after reverse transcription of the in-
tron RNA, similarly as it occurs in a site of DNA lesion
after DNA replicative polymerases disengage (53).
Introns with IEPs including an endonuclease domain,
such as Ll.LtrB, retrohome via reverse splicing into double-
stranded DNA with no replication orientation bias. Mu-
tants without DNA endonuclease activity also insert into
double-stranded DNA, but with a preference for inser-
tion into the leading-strand template (54). They cannot
cleave the second strand to generate a primer for reverse
transcription of the inserted RNA, and, instead, proba-
bly use the nascent leading strand from an approaching
replication fork as a primer for reverse transcription of
the reverse-spliced intron RNA (Figure 7B). The group II
intron retrotransposition (ectopic sites) pathway is mostly
endonuclease-independent (55), but varies between hosts
and growth conditions (56). The Ll.LtrB intron of L. lac-
tis retrotransposes into ssDNA, using the nascent Okazaki
fragment as a primer. However, in E. coli, this intron also
retrotransposes into dsDNA.
The DnaN binding motif is conserved in group II intron
En+ and En- IEPs. We therefore hypothesized that this in-
teraction would be a general feature of group II introns.
However, interaction with g that the intera-clamp does not
necessarily impose an orientation bias for intron insertion,
because there is also a g that the intera-clamp on the lead-
ing strand, but the bias toward the lagging strand template
probably reflects the availability of single-stranded target
sites and the preference for such targets among En- group
II introns, possibly because of their limited ability to un-
wind double-stranded DNA. Therefore, the retrohoming
and retrotransposition pathways of group II introns using
lagging strand primers may be facilitated by their interac-
tion with the replication machinery through the g that the
intera-clamp component of the replisome.
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